Health Condition 1: D- Radiation Therapy
Conditions
Interventions
None listed
Sponsors
Vedang Murthy
Eligibility
Inclusion criteria
Inclusion criteria: i. Histopathological diagnosis of adenocarcinoma of prostate ii. Gleason score 9 or 10 (Gleason grade group 5) iii. Disease stage at presentation: a. Absence of distant metastasis b. Any T and N Stage iv. Treated with radical intent radiotherapy to the prostate with any fractionation v. Androgen deprivation therapy received as per standard recommended surgical or medical means vi. Completion of recommended treatment radical intent radiotherapy vii. Minimum one follow-up available from the completion of radical therapy
Exclusion criteria
Exclusion criteria: i. Treatment given with palliative intent ii. Non-completion of recommended radical radiotherapy course iii. Treatment and follow up details not available after the completion of radical therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical failure free survivalTimepoint: 3 monthly for 2 years and 6 monthly for 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Distant metastasis free survivalTimepoint: 3 monthly for 2 years and 6 monthly for 5 years;Overall survivalTimepoint: 3 monthly for 2 years and 6 monthly for 5 years;Patterns of failure and recurrenceTimepoint: 3 monthly for 2 years and 6 monthly for 5 years;Prostate cancer specific survivalTimepoint: 3 monthly for 2 years and 6 monthly for 5 years;Treatment related adverse effects- acute and lateTimepoint: 3 monthly for 2 years and 6 monthly for 5 years | — |
Countries
India
Contacts
Public ContactVedang Murthy
ACTREC, Tata Memorial Centre
Outcome results
None listed